title: Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.
authors.forename: C W
authors.initials: CW
authors.lastname: Olanow
authors.forename: J H
authors.initials: JH
authors.lastname: Godbold
authors.forename: W
authors.initials: W
authors.lastname: Koller
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004311:Double-Blind Method; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy / Q000401:mortality*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012642:Selegiline / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa